This means that the ingredient can be used in Brazil to fortify food and beverage products. Prior to food and beverage approval, the ingredient received ANVISA approval for retail supplement use in 2020.
PLT Health Solutions (Morristown, NJ) has announced that its Earthlight Whole Food Vitamin D has received food and beverage approval from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária: ANVISA). This means that the ingredient can be used in Brazil to fortify food and beverage products. Prior to food and beverage approval, the ingredient received ANVISA approval for retail supplement use in 2020.
“As a whole-food, plant-based, non-GMO and organic ingredient, Earthlight supports virtually every major food and beverage market trend and will give product formulators the most transparent, cleanest label option on the market,” said Jay Martin, managing director of global sales at PLT Health Solutions, in a press release. “Consumer products companies who invest millions in their food and beverage brands need to take a close look at the way that various clean label or plant-based Vitamin D ingredients are made. From raw materials to finished product, the production process of Earthlight is completely transparent.”
According to PLT, Earthlight is produced from mushrooms using a patented process of exposing them to UV light, making it a whole food ingredient that is minimally processed without extract solvents. Earthlight is free of carriers or binders, and the company has published in the manufacturing process. The ingredient delivers 1,000 micrograms (40,000 IU) of vitamin D per gram of ingredient.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.